The most common medications to treat metastatic HER2-positive breast cancer, according to Troso-Sandoval, include: trastuzumab (Herceptin, Herzuma, Ontruzant) pertuzumab (Perjeta) trastuzumab ...
“This finding provides a new approach for cancer treatment by rewiring cancer cells rather than eliminating them,” Dr Tiffany Troso-Sandoval, a retired oncologist formerly at Memorial Sloan ...